Eltrombopag Cholin Suppliers & Bulk Manufacturers
Available Forms: Tablets / Oral suspension
Available Strengths: 12.5 mg, 25 mg, 50 mg, and 75 mg
Reference Brands: Promacta (USA), Revolade (EU)
Category: Anemia
ELTROMBOPAG CHOLIN is available in Tablets / Oral suspension and strengths such as 12.5 mg, 25 mg, 50 mg, and 75 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, ELTROMBOPAG CHOLIN is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
ELTROMBOPAG CHOLIN can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Eltrombopag, marketed under the brand names Promacta in the USA and Revolade in other countries, is an oral medication used to treat thrombocytopenia and severe aplastic anemia. It belongs to the class of thrombopoietin receptor agonists, which work by stimulating the thrombopoietin receptor on bone marrow cells, thereby promoting the production of platelets. This mechanism helps patients with abnormally low platelet counts to achieve safer levels, reducing the risk of bleeding complications.
Eltrombopag is commonly prescribed for conditions such as chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia associated with chronic hepatitis C infection. It is administered orally and is typically taken once daily, with dosing adjusted according to platelet counts and individual patient response.
Originally discovered through a research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals, eltrombopag development and marketing rights were later transferred to Novartis Pharmaceuticals. The medication has become an essential therapy for patients with platelet deficiencies, offering a non-invasive alternative to platelet transfusions and improving quality of life for individuals with chronic hematologic conditions.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Eltrombopag choline is used to treat thrombocytopenia by increasing platelet production. It is commonly prescribed for chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia associated with chronic hepatitis C.
Eltrombopag choline is a synthetic small-molecule thrombopoietin receptor agonist formulated as a choline salt for oral administration.
Eltrombopag choline is marketed under the trade names Promacta in the USA and Revolade in the EU and UK.
Eltrombopag choline products are manufactured by multiple pharmaceutical companies, including the original innovator and licensed generic manufacturers, depending on the market.
The generic name is eltrombopag choline.
The brand names are Promacta in the USA and Revolade in the EU and UK.
Eltrombopag choline formulations are manufactured in various countries including the USA, EU, and India, depending on the approved manufacturer and regulatory authorizations.
Related Products
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View Details
Ferumoxytol Injection
Strength:
30 mg/mL
Form: Injection
Reference Brands: Feraheme (USA)
View Details
Deferoxamine
Strength:
500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details
Deferasirox
Strength:
125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View DetailsQuick Response Guaranteed | Verified Suppliers
